# Children, Perennial Allergic Rhinitis (PAR), l-t Growth

> **NCT00641212** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 209 (estimated)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00641212
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 209 (ESTIMATED)
- **Last updated:** 2009-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641212, "Children, Perennial Allergic Rhinitis (PAR), l-t Growth". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00641212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*